These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 26546135)
1. Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland. Heikinheimo T; Poutiainen E; Salonen O; Elovaara I; Ristola M BMJ Open; 2015 Nov; 5(11):e007986. PubMed ID: 26546135 [TBL] [Abstract][Full Text] [Related]
2. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256 [TBL] [Abstract][Full Text] [Related]
3. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil. Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557 [TBL] [Abstract][Full Text] [Related]
4. [Neurological manifestations of the HIV infection]. Arendt G; Nolting T MMW Fortschr Med; 2005 Apr; 147 Spec No 1():75-7. PubMed ID: 16385884 [TBL] [Abstract][Full Text] [Related]
5. Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. Millikin CP; Rourke SB; Halman MH; Power C J Clin Exp Neuropsychol; 2003 Apr; 25(2):201-15. PubMed ID: 12754678 [TBL] [Abstract][Full Text] [Related]
6. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen. Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765 [TBL] [Abstract][Full Text] [Related]
7. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172 [TBL] [Abstract][Full Text] [Related]
8. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. Rabkin JG; Ferrando SJ; van Gorp W; Rieppi R; McElhiney M; Sewell M J Neuropsychiatry Clin Neurosci; 2000; 12(4):451-7. PubMed ID: 11083161 [TBL] [Abstract][Full Text] [Related]
9. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. Portegies P; Enting RH; de Gans J; Algra PR; Derix MM; Lange JM; Goudsmit J AIDS; 1993 May; 7(5):669-75. PubMed ID: 8318174 [TBL] [Abstract][Full Text] [Related]
10. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Cysique LA; Maruff P; Brew BJ Neurology; 2006 May; 66(9):1447-50. PubMed ID: 16682686 [TBL] [Abstract][Full Text] [Related]
12. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation. Wright EJ Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710 [TBL] [Abstract][Full Text] [Related]
13. Frequency and risk factors for HIV-associated neurocognitive disorder and depression in older individuals with HIV in northeastern Brazil. Fernandes Filho SM; de Melo HR Int Psychogeriatr; 2012 Oct; 24(10):1648-55. PubMed ID: 22613187 [TBL] [Abstract][Full Text] [Related]
14. Depressive symptoms and neurocognitive performance among HIV-infected women. Fialho RM; Pereira M; Mendonça N; Ouakinin S Women Health; 2013; 53(2):117-34. PubMed ID: 23517511 [TBL] [Abstract][Full Text] [Related]
15. Neurocognitive Impairment in a Chronically Well-Suppressed HIV-Infected Population: The Dutch TREVI Cohort Study. van den Dries LWJ; Wagener MN; Jiskoot LC; Visser M; Robertson KR; Adriani KS; van Gorp ECM AIDS Patient Care STDS; 2017 Aug; 31(8):329-334. PubMed ID: 28753395 [TBL] [Abstract][Full Text] [Related]
16. Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease. Perkins DO; Leserman J; Stern RA; Baum SF; Liao D; Golden RN; Evans DL Am J Psychiatry; 1995 Dec; 152(12):1776-81. PubMed ID: 8526245 [TBL] [Abstract][Full Text] [Related]
17. Empiric neurocognitive performance profile discovery and interpretation in HIV infection. Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968 [TBL] [Abstract][Full Text] [Related]
18. Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care. McCombe JA; Vivithanaporn P; Gill MJ; Power C HIV Med; 2013 Feb; 14(2):99-107. PubMed ID: 22994556 [TBL] [Abstract][Full Text] [Related]
19. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. Robertson K; Kumwenda J; Supparatpinyo K; Jiang JH; Evans S; Campbell TB; Price RW; Murphy R; Hall C; Marra CM; Marcus C; Berzins B; Masih R; Santos B; Silva MT; Kumarasamy N; Walawander A; Nair A; Tripathy S; Kanyama C; Hosseinipour M; Montano S; La Rosa A; Amod F; Sanne I; Firnhaber C; Hakim J; Brouwers P; J Neurovirol; 2011 Oct; 17(5):438-47. PubMed ID: 21786076 [TBL] [Abstract][Full Text] [Related]
20. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection. Lopardo GD; Bissio E; Iannella Mdel C; Crespo AD; Garone DB; Cassetti LI J Acquir Immune Defic Syndr; 2009 Dec; 52(4):488-92. PubMed ID: 19654553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]